← Human Trials & Peer-Reviewed Studies

Comparison of Vitamin D, Neurofeedback, and Neurofeedback Combined with Vitamin D Supplementation in Children with Attention-Deficit/Hyperactivity Disorder.

Plain-language guide to PMID 35943003 (2022): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 120 patients.

Key Facts

PMID
35943003
Journal
Archives of Iranian medicine
Year
2022
Study type
Randomized Controlled Trial
Authors
Rahmani M et al. (7 authors)
DOI
10.34172/aim.2022.47

What This Study Did, in Plain Language

What Was Tested

Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.

Nowadays, some treatments such as neurofeedback and Vitamin D Supplementation are of great importance in the treatment of attention-deficit/hyperactivity disorder (ADHD).

Who Took Part

The study group was 120 patients.

PubMed indexes the participants as children and teenagers.

In this study from March 2020 to June 2020, the researchers enrolled a total of 120 patients (6-15 years old) who were referred to the Mehr psychiatric hospital (affiliated to Lorestan University of Medical Sciences).

Patients were then randomly categorized into three experimental groups and one control group.

How the Study Was Run

In design terms this was a randomized study.

Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

The control group was given no treatment.

Vitamin D serum level was evaluated at baseline, 4, 8, and 12 weeks in all participants.

For data collection, the Parent Attention-Deficit/Hyperactivity Disorder Rating Scale-IV (ADHD-RS-IV) was applied.

The obtained information was analyzed using repeated measure variance analysis.

What Was Measured

PubMed files the paper under topics including Attention Deficit Disorder with Hyperactivity, Dietary Supplements, Neurofeedback, Vitamin D and Vitamins.

The authors tagged it with the keywords Attention-deficit/hyperactivity disorder, Brain waves, Combined treatment and Supplementation.

What This Means in Plain Language

The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc in 120 patients.

Results are reported in around 4 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2022 (Archives of Iranian medicine), a journal based in Iran.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.